数量性状位点
生物
血管紧张素II
下调和上调
表型
调节器
基因
血管紧张素转化酶2
收缩性
心功能曲线
肾素-血管紧张素系统
候选基因
基因座(遗传学)
内科学
遗传学
心力衰竭
内分泌学
细胞生物学
受体
医学
血压
传染病(医学专业)
疾病
2019年冠状病毒病(COVID-19)
作者
Michael A. Crackower,Renu Sarao,Gavin Y. Oudit,Chana Yagil,I. Kozieradzki,Sam Scanga,Antonio J. Oliveira-dos-Santos,Joan da Costa,Liyong Zhang,York Pei,James W. Scholey,Carlos M. Ferrario,Armen S. Manoukian,Mark C. Chappell,Peter H. Backx,Yoram Yagil,Josef Penninger
出处
期刊:Nature
[Springer Nature]
日期:2002-06-01
卷期号:417 (6891): 822-828
被引量:1732
摘要
Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI